NL970006I1 - Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. - Google Patents
Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.Info
- Publication number
- NL970006I1 NL970006I1 NL970006C NL970006C NL970006I1 NL 970006 I1 NL970006 I1 NL 970006I1 NL 970006 C NL970006 C NL 970006C NL 970006 C NL970006 C NL 970006C NL 970006 I1 NL970006 I1 NL 970006I1
- Authority
- NL
- Netherlands
- Prior art keywords
- disease
- medicines
- manufacture
- treat parkinson
- indolone derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878712073A GB8712073D0 (en) | 1987-05-21 | 1987-05-21 | Medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
NL970006I1 true NL970006I1 (nl) | 1997-04-01 |
NL970006I2 NL970006I2 (nl) | 1997-10-01 |
Family
ID=10617727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL970006C NL970006I2 (nl) | 1987-05-21 | 1997-02-05 | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. |
Country Status (21)
Country | Link |
---|---|
US (2) | US4824860A (nl) |
EP (1) | EP0299602B1 (nl) |
JP (1) | JPH062672B2 (nl) |
AT (1) | ATE83659T1 (nl) |
AU (1) | AU599792B2 (nl) |
CA (1) | CA1305421C (nl) |
DE (1) | DE3876877T2 (nl) |
DK (1) | DK169609B1 (nl) |
ES (1) | ES2052717T3 (nl) |
GB (1) | GB8712073D0 (nl) |
GR (1) | GR3007251T3 (nl) |
HK (1) | HK1000913A1 (nl) |
HU (1) | HU201871B (nl) |
IE (1) | IE63511B1 (nl) |
LU (1) | LU90098I2 (nl) |
MX (1) | MX9203543A (nl) |
NL (1) | NL970006I2 (nl) |
NZ (1) | NZ224709A (nl) |
PH (1) | PH23867A (nl) |
PT (1) | PT87542B (nl) |
ZA (1) | ZA883602B (nl) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9008605D0 (en) * | 1990-04-17 | 1990-06-13 | Smith Kline French Lab | Process |
GB9015095D0 (en) * | 1990-07-09 | 1990-08-29 | Smith Kline French Lab | Therapeutic method |
AU4312593A (en) * | 1992-05-18 | 1993-12-13 | Smithkline Beecham Plc | Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease |
GB9300309D0 (en) * | 1993-01-08 | 1993-03-03 | Smithkline Beecham Plc | Process |
GB9511366D0 (en) * | 1995-06-06 | 1995-08-02 | Smithkline Beecham Plc | Novel formulations |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
US5807570A (en) * | 1995-09-29 | 1998-09-15 | Cygnus, Inc. | Transdermal administration of ropinirole and analogs thereof |
GB9612752D0 (en) * | 1996-06-19 | 1996-08-21 | Smithkline Beecham Plc | Novel treatment |
AU4088897A (en) * | 1996-08-27 | 1998-03-19 | American Home Products Corporation | 4-aminoethoxy indolone derivatives |
CA2327477A1 (en) * | 1998-04-13 | 1999-10-21 | James Albert Nelson | 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists |
US6176242B1 (en) | 1999-04-30 | 2001-01-23 | Medtronic Inc | Method of treating manic depression by brain infusion |
US6218421B1 (en) * | 1999-07-01 | 2001-04-17 | Smithkline Beecham P.L.C. | Method of promoting smoking cessation |
AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
US6277875B1 (en) * | 2000-07-17 | 2001-08-21 | Andrew J. Holman | Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
US7858602B2 (en) * | 2000-10-16 | 2010-12-28 | Rodriguez Victorio C | Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells |
US6871098B2 (en) * | 2000-10-30 | 2005-03-22 | Medtronic, Inc. | Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule |
CN1681512B (zh) * | 2002-09-13 | 2011-11-09 | 默塔克神经科学有限公司 | 2,3-苯并二氮杂草在制备治疗与基底神经节相关的运动疾病的药物中的应用 |
WO2004026299A1 (en) * | 2002-09-17 | 2004-04-01 | Motac Neuroscience Limited | Treatment of dyskinesia |
DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
US20050250803A1 (en) * | 2003-11-26 | 2005-11-10 | Pfizer Inc | Combination of dopamine agonists and monoamine reuptake inhibitors |
DE10361258A1 (de) * | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson |
US7378439B2 (en) * | 2004-01-20 | 2008-05-27 | Usv, Ltd. | Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
US20050197385A1 (en) * | 2004-02-20 | 2005-09-08 | Schwarz Pharma Ag | Use of rotigotine for treatment or prevention of dopaminergic neuron loss |
DE102004014841B4 (de) * | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms |
US20090325911A1 (en) * | 2005-10-21 | 2009-12-31 | Caritas St. Elizabeth Medical Center Of Boston, Inc. | Use of Androgens for the Treatment of Parkinson's Disease |
DK2010184T3 (da) * | 2006-04-06 | 2013-03-25 | Nupathe Inc | Implatanter til behandlingen af dopamin associerede tilstande |
TW200815045A (en) * | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
WO2008001204A2 (en) * | 2006-06-29 | 2008-01-03 | Antares Pharma Ipl Ag | Transdermal compositions of pramipexole having enhanced permeation properties |
US20090247537A1 (en) * | 2008-03-25 | 2009-10-01 | William Dale Overfield | Methods for preventing or treating bruxism using dopaminergic agents |
CN101574341B (zh) * | 2008-05-05 | 2012-12-19 | 北京德众万全医药科技有限公司 | 一种罗匹尼罗的口服固体药物组合物 |
US20110195117A1 (en) * | 2008-09-01 | 2011-08-11 | Lupin Limited | Controlled release compositions of ropinirole |
CA2738414C (en) | 2008-09-29 | 2014-05-27 | Wockhardt Research Centre | Extended release dosage form of ropinirole |
WO2010044108A2 (en) | 2008-10-17 | 2010-04-22 | Rubicon Research Private Limited | Controlled release formulations of ropinirole |
US20100233259A1 (en) * | 2008-12-12 | 2010-09-16 | Pascal Grenier | Dosage form of ropinirole |
UA103851C2 (en) | 2010-04-30 | 2013-11-25 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Propylaminoindan transdermal composition |
CN103476404B (zh) | 2011-03-24 | 2017-09-29 | 帝国制药美国公司 | 包含活性剂层和活性剂转化层的透皮组合物 |
EP2776020B1 (en) | 2011-11-09 | 2019-09-11 | Teikoku Seiyaku Co., Ltd. | Methods for the treatment of skin neoplasms |
AU2013338243B2 (en) | 2012-11-02 | 2016-09-29 | Teikoku Seiyaku Co., Ltd. | Propynylaminoindan transdermal compositions |
WO2015168616A1 (en) * | 2014-05-02 | 2015-11-05 | Abbvie Inc. | Neuronal nicotinic agonists and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
US4588740A (en) * | 1982-12-07 | 1986-05-13 | Smithkline Beckman Corporation | Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones |
-
1987
- 1987-05-21 GB GB878712073A patent/GB8712073D0/en active Pending
-
1988
- 1988-05-16 IE IE146988A patent/IE63511B1/en not_active IP Right Cessation
- 1988-05-16 PH PH36934A patent/PH23867A/en unknown
- 1988-05-17 CA CA000566974A patent/CA1305421C/en not_active Expired - Lifetime
- 1988-05-19 NZ NZ224709A patent/NZ224709A/en unknown
- 1988-05-19 US US07/196,653 patent/US4824860A/en not_active Expired - Lifetime
- 1988-05-19 AT AT88304555T patent/ATE83659T1/de active
- 1988-05-19 ES ES88304555T patent/ES2052717T3/es not_active Expired - Lifetime
- 1988-05-19 DK DK275488A patent/DK169609B1/da not_active IP Right Cessation
- 1988-05-19 AU AU16445/88A patent/AU599792B2/en not_active Expired
- 1988-05-19 EP EP88304555A patent/EP0299602B1/en not_active Expired - Lifetime
- 1988-05-19 DE DE8888304555T patent/DE3876877T2/de not_active Expired - Lifetime
- 1988-05-20 HU HU882611A patent/HU201871B/hu unknown
- 1988-05-20 ZA ZA883602A patent/ZA883602B/xx unknown
- 1988-05-20 JP JP63124816A patent/JPH062672B2/ja not_active Expired - Lifetime
- 1988-05-20 PT PT87542A patent/PT87542B/pt not_active IP Right Cessation
-
1989
- 1989-03-13 US US07/322,386 patent/US4912126A/en not_active Expired - Lifetime
-
1992
- 1992-06-26 MX MX9203543A patent/MX9203543A/es unknown
-
1993
- 1993-03-05 GR GR930400472T patent/GR3007251T3/el unknown
-
1997
- 1997-02-05 NL NL970006C patent/NL970006I2/nl unknown
- 1997-07-16 LU LU90098C patent/LU90098I2/fr unknown
- 1997-12-19 HK HK97102520A patent/HK1000913A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3876877D1 (de) | 1993-02-04 |
PH23867A (en) | 1989-11-23 |
MX9203543A (es) | 1992-07-01 |
IE63511B1 (en) | 1995-05-03 |
HUT47217A (en) | 1989-02-28 |
ES2052717T3 (es) | 1994-07-16 |
AU1644588A (en) | 1988-11-24 |
DE3876877T2 (de) | 1993-04-29 |
PT87542B (pt) | 1992-09-30 |
CA1305421C (en) | 1992-07-21 |
US4824860A (en) | 1989-04-25 |
JPS63303966A (ja) | 1988-12-12 |
GR3007251T3 (nl) | 1993-07-30 |
US4912126A (en) | 1990-03-27 |
GB8712073D0 (en) | 1987-06-24 |
JPH062672B2 (ja) | 1994-01-12 |
NZ224709A (en) | 1997-02-24 |
DK275488D0 (da) | 1988-05-19 |
EP0299602A3 (en) | 1990-06-06 |
NL970006I2 (nl) | 1997-10-01 |
PT87542A (pt) | 1989-05-31 |
ATE83659T1 (de) | 1993-01-15 |
AU599792B2 (en) | 1990-07-26 |
IE881469L (en) | 1988-11-21 |
EP0299602A2 (en) | 1989-01-18 |
HU201871B (en) | 1991-01-28 |
DK275488A (da) | 1988-11-22 |
EP0299602B1 (en) | 1992-12-23 |
DK169609B1 (da) | 1994-12-27 |
ZA883602B (en) | 1989-04-26 |
LU90098I2 (fr) | 1997-09-25 |
HK1000913A1 (en) | 1998-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL970006I1 (nl) | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
AU4732989A (en) | Pyrimidines and their pharmaceutical acceptable salts thereof, and their use as medicines | |
NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
FI862011A0 (fi) | Terapeutiska nukleosider. | |
DE3875769D1 (de) | Therapeutische nukleoside. | |
MX9306049A (es) | Dinucleotido de nicotinamida-ademina y fosfato de dinucleotido de nicotinamida-adenina como farmacos para tratar la enfermedad de alzheimer. | |
AU655958B2 (en) | Use of quisqualate-receptor antagonists for treating Parkinson's disease | |
ES2108680T3 (es) | Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento. | |
DE10299023I2 (de) | Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff | |
NO168040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater. | |
GR3034062T3 (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
GB8608893D0 (en) | D-nor-7-ergoline derivatives | |
HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
KR890001555A (ko) | 요산 배설용 조성물 | |
OA09790A (en) | "Paromomycin or its derivatives or salts thereof for parenteral treatment of human parasitic diseases". | |
EP0202986A3 (en) | Use of "naftidrofuryl" in the treatment of neuropathies |